ArticleFrontiers in pharmacology2026

Neoadjuvant almonertinib as a bridging strategy to surgery in resectable lung cancer with active COVID-19: a case report.

Shihui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.